• Barts MS Blog,  Monthly MS News,  MS,  Multiple Sclerosis

    MS News: April 2016

    Highlight! New injectable multiple sclerosis drug given go-ahead  Smoking Cessation Decelerates Brain Volume Loss in Multiple Sclerosis Research Catching glandular fever can prevent multiple sclerosis Drug boosts myelin regeneration in mice raising hope of future treatments for MS Gut Bacteria Affects Myelin Content and Induces MS-Like Depression in Mice, Study Reportsultiple sclerosis development risk linked with where you live The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities A Way Forward in Treating Primary-Progressive Multiple Sclerosis? Study Shows Potential of Novel Compound to Treat Multiple Sclerosis Cytokine Once Thought Only to Promote Inflammation Now Seen to Have Restorative Properties, Too Multiple sclerosis: A new leap forward? Technique measures ‘postural sway’ to diagnose neuromuscular disorders Multiple sclerosis Could Helicobacter pylori provide protection against multiple sclerosis?

  • Barts MS Blog,  Monthly MS News,  MS,  Multiple Sclerosis

    MS News: March 2016

    Highlight! Researchers spill the beans on coffee and MS Health Benefits Of Coffee: Multiple Sclerosis Risk Lower In People Who Drink More Java Daily Coffee may help combat Multiple Sclerosis (MS) Research Diabetic Oral Drugs Like Metformin Eased MS Symptoms in People with Both Diseases, Study Reports Signaling Molecule Seen to Induce CNS Remyelination in Mice with Spinal Injuries Oral MS Drug Derived from Plant Peptide Seen to Stop Disease Progression in Mice

  • Barts MS Blog,  Monthly MS News,  MS,  Multiple Sclerosis

    MS News: February 2016

    Highlight! SHEMAR MOORE JOINS KISS GOODBYE ACTRIMS 2016 ACTRIMS 2016 Talk Weighs Clinical Differences, Similarities in 2 Major Forms of MS Results of New SPMS Study to Be Presented at ACTRIMS Effects of Specific Antibodies on MS Neurodegeneration to Be Presented at ACTRIMS Forum Treadmill Exercise Benefits MS Patients, According to Study Presented at ACTRIMS Forum NIH Study into Progressive MS Biomarkers to Be Presented at ACTRIMS 2016 ACTRIMS Session on MS Progression to Emphasize Continuing Treatment of Advancing Disease